World's Best Scientists 2026 revealed!
Miguel Bernardo

Miguel Bernardo

D-Index & Metrics

Psychology

D-Index
71
Citations
17741
World Ranking
2180
National Ranking
18

Miguel Bernardo publication distribution in Psychology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Psychology in 2026. The highlighted bar marks where Miguel Bernardo sits on this spectrum.

31–40 publications: 6 scientists 41–50 publications: 52 scientists 51–60 publications: 138 scientists 61–70 publications: 299 scientists 71–80 publications: 461 scientists 81–90 publications: 605 scientists 91–100 publications: 713 scientists 101–110 publications: 736 scientists 111–120 publications: 686 scientists 121–130 publications: 670 scientists 131–140 publications: 644 scientists 141–150 publications: 597 scientists 151–160 publications: 576 scientists 161–170 publications: 477 scientists 171–180 publications: 450 scientists 181–190 publications: 397 scientists 191–200 publications: 343 scientists 201–210 publications: 328 scientists 211–220 publications: 313 scientists 221–230 publications: 283 scientists 231–240 publications: 226 scientists 241–250 publications: 196 scientists 251–260 publications: 201 scientists 261–270 publications: 171 scientists 271–280 publications: 151 scientists 281–290 publications: 139 scientists 291–300 publications: 113 scientists 301–310 publications: 102 scientists 311–320 publications: 100 scientists 321–330 publications: 76 scientists 331–340 publications: 92 scientists 341–350 publications: 85 scientists 351–360 publications: 69 scientists 361–370 publications: 71 scientists 371–380 publications: 63 scientists 381–390 publications: 58 scientists 391–400 publications: 57 scientists 401–410 publications: 43 scientists 411–420 publications: 33 scientists 421–430 publications: 50 scientists 431–440 publications: 41 scientists 441–450 publications: 32 scientists 451–460 publications: 27 scientists 461–470 publications: 28 scientists 471–480 publications: 25 scientists 481–490 publications: 28 scientists 491–500 publications: 20 scientists 501–510 publications: 23 scientists 511–520 publications: 26 scientists 521–530 publications: 17 scientists 531–540 publications: 21 scientists 541–550 publications: 14 scientists 551–560 publications: 16 scientists 561–570 publications: 10 scientists 571–580 publications: 22 scientists 581–590 publications: 9 scientists 591–600 publications: 14 scientists 601–610 publications: 9 scientists 611–620 publications: 11 scientists 621–630 publications: 4 scientists 631–640 publications: 7 scientists 641–650 publications: 5 scientists 651–660 publications: 10 scientists 661–670 publications: 8 scientists 671–680 publications: 8 scientists 681–690 publications: 4 scientists 691–700 publications: 3 scientists 701–704 publications: 4 scientists 705+ publications: 100 scientists
31 publications 705+

This scientist: 482 publications — 97th percentile

97% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 705 publications or more.

Miguel Bernardo D-index placement in Psychology in 2026

The chart shows the D-index (discipline H-index) distribution of Psychology scientists ranked by Research.com in 2026. The highlighted bar marks where Miguel Bernardo sits on this spectrum.

30–31 D-Index: 398 scientists 32–33 D-Index: 702 scientists 34–35 D-Index: 671 scientists 36–37 D-Index: 659 scientists 38–39 D-Index: 641 scientists 40–41 D-Index: 671 scientists 42–43 D-Index: 617 scientists 44–45 D-Index: 558 scientists 46–47 D-Index: 495 scientists 48–49 D-Index: 487 scientists 50–51 D-Index: 445 scientists 52–53 D-Index: 390 scientists 54–55 D-Index: 408 scientists 56–57 D-Index: 345 scientists 58–59 D-Index: 325 scientists 60–61 D-Index: 321 scientists 62–63 D-Index: 248 scientists 64–65 D-Index: 290 scientists 66–67 D-Index: 218 scientists 68–69 D-Index: 219 scientists 70–71 D-Index: 215 scientists 72–73 D-Index: 183 scientists 74–75 D-Index: 169 scientists 76–77 D-Index: 132 scientists 78–79 D-Index: 137 scientists 80–81 D-Index: 120 scientists 82–83 D-Index: 112 scientists 84–85 D-Index: 86 scientists 86–87 D-Index: 101 scientists 88–89 D-Index: 83 scientists 90–91 D-Index: 77 scientists 92–93 D-Index: 70 scientists 94–95 D-Index: 78 scientists 96–97 D-Index: 58 scientists 98–99 D-Index: 53 scientists 100–101 D-Index: 57 scientists 102–103 D-Index: 48 scientists 104–105 D-Index: 53 scientists 106–107 D-Index: 46 scientists 108–109 D-Index: 24 scientists 110–111 D-Index: 35 scientists 112–113 D-Index: 27 scientists 114–115 D-Index: 32 scientists 116–117 D-Index: 31 scientists 118–119 D-Index: 22 scientists 120–121 D-Index: 16 scientists 122–123 D-Index: 24 scientists 124–125 D-Index: 18 scientists 126–127 D-Index: 11 scientists 128–129 D-Index: 19 scientists 130–131 D-Index: 10 scientists 132–133 D-Index: 16 scientists 134–135 D-Index: 10 scientists 136–137 D-Index: 12 scientists 138–139 D-Index: 8 scientists 140–141 D-Index: 5 scientists 142–143 D-Index: 12 scientists 144+ D-Index: 98 scientists
30 D-Index 144+

This scientist: 71 D-Index — 82nd percentile

82% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 144 D-Index or more.

Overview

Miguel Bernardo is affiliated with the University of Barcelona in Spain. Their research spans multiple fields, with a primary focus on Medicine and Psychology. Key subfields include Psychiatry and Mental Health, Clinical Psychology, Cognitive Neuroscience, Genetics, and Biological Psychiatry.

The scientist's research covers several main topics, such as:

  • Schizophrenia research and treatment
  • Bipolar Disorder and Treatment
  • Child and Adolescent Psychosocial and Emotional Development
  • Genetic Associations and Epidemiology
  • Tryptophan and brain disorders
  • Functional Brain Connectivity Studies
  • Mental Health Research Topics

Miguel Bernardo has contributed significant work to various publication venues, including:

  • European Neuropsychopharmacology
  • Psychological Medicine
  • Schizophrenia Bulletin
  • Schizophrenia Research
  • Spanish Journal of Psychiatry and Mental Health

Selected recent papers highlight their engagement with the impact of the COVID-19 pandemic on mental health and psychosis research:

  • Resilience and mental health during the COVID-19 pandemic, 2021, Journal of Affective Disorders
  • Effects of the COVID-19 pandemic and lockdown in Spain: comparison between community controls and patients with a psychiatric disorder. Preliminary results from the BRIS-MHC STUDY., 2020, Journal of Affective Disorders
  • Social disadvantage, linguistic distance, ethnic minority status and first-episode psychosis: results from the EU-GEI case-control study, 2020, Psychological Medicine
  • The EUropean Network of National Schizophrenia Networks Studying Gene-Environment Interactions (EU-GEI): Incidence and First-Episode Case-Control Programme, 2020, Social Psychiatry and Psychiatric Epidemiology
  • Daily use of high-potency cannabis is associated with more positive symptoms in first-episode psychosis patients: the EU-GEI case-control study, 2020, Psychological Medicine

Their frequent co-authors include Sílvia Amoretti, Gisela Mezquida, Eduard Vieta, Ana González-Pinto, and Mara Parellada.

Miguel Bernardo has also contributed to book publications, including a title published by Editora Schreiben eBooks:

  • EDUCAÇÃO, TECNOLOGIA E INCLUSÃO: CONSTRUÇÃO E DESAFIOS, scheduled for 2025

Best Publications

  • The contribution of cannabis use to variation in the incidence of psychotic disorder across Europe (EU-GEI): a multicentre case-control study

    Marta Di Forti;Marta Di Forti;Marta Di Forti;Diego Quattrone;Diego Quattrone;Diego Quattrone;Tom P. Freeman;Giada Tripoli

  • Assessment and management of agitation in psychiatry: Expert consensus

    Marina Garriga;Isabella Pacchiarotti;Siegfried Kasper;Scott L Zeller

  • Standardized remission criteria in schizophrenia

    J van Os;T Burns;R Cavallaro;S Leucht

  • Double-blind, placebo-controlled comparison of intramuscular olanzapine and intramuscular haloperidol in the treatment of acute agitation in schizophrenia.

    Padraig Wright;Martin Birkett;Stacy R. David;Karena Meehan

  • Identifying Gene-Environment Interactions in Schizophrenia: Contemporary Challenges for Integrated, Large-scale Investigations

    Jim van Os;Jim van Os;Bart P. Rutten;Inez Myin-Germeys;Philippe Delespaul

  • Treated Incidence of Psychotic Disorders in the Multinational EU-GEI Study.

    Hannah Jongsma;Charlotte Gayer-Anderson;Antonio Lasalvia;Diego Quattrone

  • Metabolic profile of antipsychotic-naive individuals with non-affective psychosis.

    Emilio Fernandez-Egea;Miguel Bernardo;Thomas Donner;Ignacio Conget

  • International trends in clozapine use: a study in 17 countries

    C. J. Bachmann;L. Aagaard;M. Bernardo;L. Brandt

  • International trends in antipsychotic use: A study in 16 countries, 2005-2014

    Óskar Hálfdánarson;Helga Zoëga;Lise Aagaard;Miquel Bernardo

  • Prefrontal and temporal blood flow in schizophrenia: resting and activation technetium-99m-HMPAO SPECT patterns in young neuroleptic-naive patients with acute disease

    Ana M. Catafau;Eduard Parellada;Francisco J. Lomeña;Miquel Bernardo

  • White Noise Speech Illusions : A Trait-Dependent Risk Marker for Psychotic Disorder?

    Elaine Schepers;Richel Lousberg;Sinan Guloksuz;Lotta-Katrin Pries

  • Dignificando una terapia electroconvulsiva basada en la evidencia

    Miguel Bernardo;Mikel Urretavizcaya

  • Brain Effects of Cognitive Remediation Therapy in Schizophrenia: A Structural and Functional Neuroimaging Study

    Rafael Penadés;Nuria Pujol;Rosa Catalán;Guillem Massana

  • Sustained attention impairment correlates to gray matter decreases in first episode neuroleptic-naive schizophrenic patients.

    Pilar Salgado-Pineda;Immaculada Baeza;Mercedes Pérez-Gómez;Pere Vendrell

  • Inflammation in schizophrenia: A question of balance.

    Juan C. Leza;Borja García-Bueno;Miquel Bioque;Celso Arango

  • Amisulpride and olanzapine followed by open-label treatment with clozapine in first-episode schizophrenia and schizophreniform disorder (OPTiMiSE): a three-phase switching study.

    René S Kahn;Inge Winter van Rossum;Stefan Leucht;Philip McGuire;Philip McGuire

  • Pro-/Anti-inflammatory Dysregulation in Patients With First Episode of Psychosis: Toward an Integrative Inflammatory Hypothesis of Schizophrenia

    Borja García-Bueno;Miquel Bioque;Karina S. Mac-Dowell;M. Fe Barcones

  • Examining the independent and joint effects of molecular genetic liability and environmental exposures in schizophrenia: results from the EUGEI study

    Sinan Guloksuz;Lotta-Katrin Pries;Philippe Delespaul;Gunter Kenis

  • Resilience and mental health during the COVID-19 pandemic.

    Norma Verdolini;Silvia Amoretti;Laura Montejo;Clemente García-Rizo

  • Decreased cerebral activation during CPT performance: structural and functional deficits in schizophrenic patients.

    Pilar Salgado-Pineda;Carme Junqué;Pere Vendrell;Immaculada Baeza

  • Clinical usefulness of the screen for cognitive impairment in psychiatry (SCIP-S) scale in patients with type I bipolar disorder

    Georgina Guilera;Oscar Pino;Juana Gómez-Benito;J Emilio Rojo

Frequent Co-Authors

Jim van Os
Jim van Os University Medical Center Utrecht
Eduard Vieta
Eduard Vieta University of Barcelona
Julio Bobes
Julio Bobes University of Oviedo
Ana González-Pinto
Ana González-Pinto University of the Basque Country
Julio Sanjuan
Julio Sanjuan University of Valencia
Antonio Lobo
Antonio Lobo University of Zaragoza
Manuel J. Cuesta
Manuel J. Cuesta Hospital Universitario de Navarra
Josefina Castro-Fornieles
Josefina Castro-Fornieles University of Barcelona
Bart P. F. Rutten
Bart P. F. Rutten Maastricht University Medical Centre
Celso Arango
Celso Arango Complutense University of Madrid

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring psychology in the USA opens doors to diverse career pathways, many of which can be pursued through online degrees. Social work is a popular choice for psychology graduates looking to make a direct impact in their communities. Each state has specific requirements and processes to enter this rewarding profession.

For example, if you’re interested in how to become a social worker in New Jersey, you’ll find particular academic and licensing steps that must be followed. In New Mexico, becoming a social worker in New Mexico requires understanding state-specific certifications and fieldwork expectations.

Students considering the Northeast can review the requirements to be a social worker in New York, which include accredited degrees and practical experience. Meanwhile, those looking at the Southeast should investigate North Carolina social work education requirements for a tailored pathway.

Exploring these resources helps prospective students choose the right online degree and career direction, ensuring a strong foundation for future professional success.

Best Scientists Citing Miguel Bernardo

Trending Scientists

Recently Published Articles